230. The significance of HER-2 amplification and the size and type of pathological unicentric, initially operable clinical stage I and IIA/IIB breast cancer, in determining the treatment strategy
Autor: | Miletic, N., Golubicic, I., Gavrilovic, D., Dzodic, R., Pavlovic, T., Nikitovic, M., Stojiljkovic, D., Karaferic, A., Pupic, G. |
---|---|
Zdroj: | In European Journal of Surgical Oncology September 2012 38(9):808-808 |
Databáze: | ScienceDirect |
Externí odkaz: |